Casacuberta-Serra, Sílvia https://orcid.org/0000-0002-2595-1115
González-Larreategui, Íñigo
Capitán-Leo, Daniel
Soucek, Laura https://orcid.org/0000-0002-4750-7971
Article History
Received: 12 January 2024
Revised: 5 June 2024
Accepted: 24 June 2024
First Online: 21 August 2024
Competing interests
: S.C.-S. is the author of patents directly or indirectly connected to cancer treatment (EP20710558, EP22383031, EP23382345 and EP23382552) and is an employee and shareholder of Peptomyc S.L., a company that develops therapeutics for cancer treatment. I.G.-L. is the author of one patent connected to cancer treatment (EP23382552). L.S. is the CEO and shareholder of Peptomyc S.L., a company that develops therapeutics for cancer treatment, and received consulting fees from it; she is author of patents directly or indirectly connected to cancer treatment (EP13382167, EP16382339, EP19382195, EP19382194, EP22383031, EP22383028, EP23382345, EP23382552, EP23382553 and EP2338255).